A

Aligos Therapeutics
D

ALGS

9.94000
USD
0.29
(3.01%)
مغلق
حجم التداول
0
الربح لكل سهم
-9
العائد الربحي
-
P/E
-1
حجم السوق
61,166,605
الأخبار المقالات

العنوان: Aligos Therapeutics Inc

القطاع: Healthcare
الصناعة: Biotechnology
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.